Cassava Sciences reported $1.21M in Interest Income for its fiscal quarter ending in June of 2025.


Interest Income Change Date
Abbott USD 71M 11M Jun/2025
Biogen USD 32.3M 8.4M Jun/2025
Cassava Sciences USD 1.21M 586K Jun/2025
Eisai 3.11B 783M Mar/2024
Eli Lilly USD 40M 8.3M Jun/2025
Geron USD 4.66M 496K Jun/2025
J&J 332M 51M Mar/2025
Merck USD 109M 37M Mar/2025
Pfizer USD 156M 13M Jun/2025
Roche Holding 2M 12M Dec/2020